Insider · CIK 0001200796
Richard C Pfenniger Jr
Files at OPK (OPKO HEALTH, INC.), COCP (Cocrystal Pharma, Inc.), FLNT (Fluent, Inc.), WGS (GeneDx Holdings Corp.). First filing -, latest -.
Richard C Pfenniger Jr files SEC Form 4 as director at OPK (OPKO HEALTH, INC.), and also at COCP (Cocrystal Pharma, Inc.), FLNT (Fluent, Inc.), WGS (GeneDx Holdings Corp.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Richard C Pfenniger Jr has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 9, 2026 | COCP Cocrystal Pharma, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +16,410 | $0.00 | $0 | 16,410 | Jan 13, 2026 |
| Oct 28, 2025 | COCP Cocrystal Pharma, Inc. | AGrant or award Common Stock | +20,000 | - | - | 31,400 | Oct 30, 2025 |
| Oct 28, 2025 | COCP Cocrystal Pharma, Inc. | AGrant or award Warrantsderivative | +40,000 | $1.39 | $56k | 40,000 | Oct 30, 2025 |
| Jun 18, 2025 | FLNT Fluent, Inc. | AGrant or award Common Stock | +39,682 | $0.00 | $0 | 90,341 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +12,924 | $0.00 | $0 | 41,506 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | AGrant or award Restricted Stock Unitderivative | +3,576 | $0.00 | $0 | 3,576 | Jun 23, 2025 |
| Jun 18, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -12,924 | $0.00 | $0 | 0 | Jun 23, 2025 |
| May 2, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Class A Common Stock | +918 | $0.00 | $0 | 28,582 | May 5, 2025 |
| May 2, 2025 | WGS GeneDx Holdings Corp. | MOption exercise Restricted Stock Unitderivative | -918 | $0.00 | $0 | 0 | May 5, 2025 |
| Apr 23, 2025 | OPK OPKO HEALTH, INC. | AGrant or award Stock Option (Right to Buy)derivative | +60,000 | $0.00 | $0 | 60,000 | Apr 23, 2025 |
| Oct 9, 2024 | COCP Cocrystal Pharma, Inc. | AGrant or award Common Stock | +8,067 | - | - | 11,400 | Oct 11, 2024 |
Questions about Richard C Pfenniger Jr
Answered from the filings on this page, as of the latest one.
Is Richard C Pfenniger Jr buying or selling?
Richard C Pfenniger Jr has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Richard C Pfenniger Jr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Richard C Pfenniger Jr has 0.
Where does Richard C Pfenniger Jr file Form 4?
Richard C Pfenniger Jr has filed Form 4 at OPK (OPKO HEALTH, INC.); COCP (Cocrystal Pharma, Inc.); FLNT (Fluent, Inc.); WGS (GeneDx Holdings Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.